Gantuja Bold

761 total citations
8 papers, 437 citations indexed

About

Gantuja Bold is a scholar working on Epidemiology, Transplantation and Immunology. According to data from OpenAlex, Gantuja Bold has authored 8 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Transplantation and 4 papers in Immunology. Recurrent topics in Gantuja Bold's work include Renal Transplantation Outcomes and Treatments (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and T-cell and B-cell Immunology (2 papers). Gantuja Bold is often cited by papers focused on Renal Transplantation Outcomes and Treatments (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and T-cell and B-cell Immunology (2 papers). Gantuja Bold collaborates with scholars based in Germany, Czechia and Spain. Gantuja Bold's co-authors include Petra Reinke, Hans‐Dieter Volk, Peter Nickel, Constanze Schönemann, Johann Pratschke, Nina Babel, Stefan G. Tullius, Anett Sefrin, Christian Meisel and Mir‐Farzin Mashreghi and has published in prestigious journals such as Transplantation, American Journal of Transplantation and Transplant Immunology.

In The Last Decade

Gantuja Bold

8 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gantuja Bold Germany	7	239	170	138	125	109	8	437
A. Benedict Cosimi United States	8	106 0.4×	182 1.1×	113 0.8×	102 0.8×	86 0.8×	11	420
K.A.M.I. van Donselaar–van der Pant Netherlands	11	137 0.6×	129 0.8×	66 0.5×	59 0.5×	114 1.0×	18	379
Caroline Wehmeier Switzerland	13	349 1.5×	107 0.6×	175 1.3×	110 0.9×	73 0.7×	31	455
M. Harler United States	5	454 1.9×	171 1.0×	253 1.8×	74 0.6×	140 1.3×	13	610
Anett Sefrin Germany	7	136 0.6×	84 0.5×	58 0.4×	253 2.0×	68 0.6×	9	374
Tatiana Michelon Brazil	12	101 0.4×	66 0.4×	69 0.5×	37 0.3×	142 1.3×	36	367
Dominique Masson France	12	156 0.7×	57 0.3×	82 0.6×	51 0.4×	215 2.0×	49	470
Suxiao Yang United States	7	195 0.8×	82 0.5×	80 0.6×	48 0.4×	363 3.3×	11	520
Andrea Ruhenstroth Germany	11	371 1.6×	210 1.2×	235 1.7×	82 0.7×	126 1.2×	19	565
Laura Lees United States	6	253 1.1×	170 1.0×	143 1.0×	63 0.5×	165 1.5×	10	463

Countries citing papers authored by Gantuja Bold

Since Specialization

Citations

This map shows the geographic impact of Gantuja Bold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gantuja Bold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gantuja Bold more than expected).

Fields of papers citing papers by Gantuja Bold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gantuja Bold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gantuja Bold. The network helps show where Gantuja Bold may publish in the future.

Co-authorship network of co-authors of Gantuja Bold

This figure shows the co-authorship network connecting the top 25 collaborators of Gantuja Bold. A scholar is included among the top collaborators of Gantuja Bold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gantuja Bold. Gantuja Bold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Viklický, Ondřej, Gantuja Bold, Oriol Bestard, et al.. (2023). Tacrolimus After rATG and Infliximab Induction Immunosuppression—RIMINI Trial. Transplantation. 108(1). 242–251. 1 indexed citations

Babel, Nina, Gantuja Bold, Steffen Arnold, et al.. (2009). Sustained BK Viruria as an Early Marker for the Development of BKV-Associated Nephropathy: Analysis of 4128 Urine and Serum Samples. Transplantation. 88(1). 89–95. 81 indexed citations

Nickel, Peter, Gantuja Bold, Nina Babel, et al.. (2008). High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function. Transplant Immunology. 20(4). 238–242. 60 indexed citations

Babel, Nina, Claas Ulrich, Gantuja Bold, et al.. (2007). Development of Kaposi's sarcoma under sirolimus‐based immunosuppression and successful treatment with imiquimod. Transplant Infectious Disease. 10(1). 59–62. 31 indexed citations

Nickel, Peter, Gantuja Bold, Constanze Schönemann, et al.. (2006). Modified ELISPOT technique — Highly significant inverse correlation of post-Tx donor-reactive IFNγ-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients. Transplant Immunology. 16(3-4). 232–237. 40 indexed citations

Nickel, Peter, Gantuja Bold, Astrid Friebe, et al.. (2005). CD31+ Naïve Th Cells Are Stable during Six Months Following Kidney Transplantation: Implications for Post-transplant Thymic Function. American Journal of Transplantation. 5(7). 1764–1771. 16 indexed citations

Kotsch, Katja, Mir‐Farzin Mashreghi, Gantuja Bold, et al.. (2004). ENHANCED GRANULYSIN mRNA EXPRESSION IN URINARY SEDIMENT IN EARLY AND DELAYED ACUTE RENAL ALLOGRAFT REJECTION. Transplantation. 77(12). 1866–1875. 85 indexed citations

Nickel, Peter, Gantuja Bold, Constanze Schönemann, et al.. (2004). Enzyme-Linked Immunosorbent Spot Assay for Donor-Reactive Interferon-Gamma-Producing Cells Identifies T-Cell Presensitization and Correlates with Graft Function at 6 and 12 Months in Renal-Transplant Recipients. Transplantation. 78(11). 1640–1646. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact